Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Compared with the non-diabetic comparison group, participants with T2DM had significantly higher chemerin (p < 0.001) and significantly lower 25(OH)D (p < 0.001).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants were classified as having MetS according to IDF criteria, and vitamin D status was classified using serum 25(OH)D concentrations as deficient, insufficient, or sufficient.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association of 25-hydroxyvitamin D and chemerin with metabolic syndrome components in individuals with type 2 diabetes mellitus

Study design awaiting verification · Frontiers in Medicine · 2026

Original publication title

Association of 25-hydroxyvitamin D and chemerin with metabolic syndrome components in individuals with type 2 diabetes mellitus

Mukhtiar Baig; Zohair Jamil Gazzaz; Mohamad Nidal Khabaz; Shahad Abduljalil Abualhamael; Sami Hamdan Alzahrani; Wail A. Alamoudi

Copyright © 2026 Baig, Gazzaz, Khabaz, Abualhamael, Alzahrani and Alamoudi.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Individuals with T2DM showed lower serum 25(OH)D and increased chemerin concentrations than non-diabetic comparison participants. Chemerin was higher in participants with MetS, whereas neither 25(OH)D nor chemerin was independently associated with MetS in the adjusted logistic model. These findings support an association, rather than a causal or diagnostic relationship, between 25(OH)D, chemerin, and cardiometabolic disturbance in this cohort. Further longitudinal and interventional studies are required.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

This study investigated the associations of serum 25-hydroxyvitamin D [25(OH)D], the principal circulating marker used to assess vitamin D status, and chemerin with metabolic syndrome (MetS) components in individuals with type 2 diabetes mellitus (T2DM) and in a non-diabetic comparison group. The MetS components assessed were central obesity/waist circumference, blood pressure, fasting plasma glucose, triglycerides, and HDL-C, because these are the diagnostic elements of the International Diabetes Federation (IDF) definition.

Source: Background

Abstract: What methods does the paper describe?

This cross-sectional analytical study was conducted at King Abdulaziz University, Rabigh, between August 2021 and December 2022. Participants were classified as having MetS according to IDF criteria, and vitamin D status was classified using serum 25(OH)D concentrations as deficient, insufficient, or sufficient. Serum 25(OH)D, chemerin, and CRP were measured by ELISA.

Source: Methods

Abstract: Results

A total of 176 participants were included in the study (88 with diabetes and 88 non-diabetic comparison participants), with equal sex distribution in both groups (44 females and 44 males per group). Compared with the non-diabetic comparison group, participants with T2DM had significantly higher chemerin (p < 0.001) and significantly lower 25(OH)D (p < 0.001). The MetS was more common in diabetic participants than in non-diabetic comparison participants: 70/88 (79.5%) vs. 43/88 (48.9%) (p < 0.001). Blood chemerin levels were also elevated in those with MetS compared with those without MetS (p = 0.032).

Within the diabetic group, 18/88 (20.5%) had 25(OH)D deficiency and 47/88 (53.4%) had insufficient levels, whereas among non-diabetic comparison participants, 7/88 (8%) had deficiency and 32/88 (36.4%) had insufficient levels (p < 0.001). Higher FPG, insulin, HOMA-IR, HbA1c, TC, and CRP were associated with lower 25(OH)D in diabetic subjects. The latter inverse relationships were also observed in the MetS subgroup. Chemerin was associated with HOMA-IR, FPG, TC, CRP, and HbA1c in diabetic subjects. In the MetS subgroup, FPG, insulin, HOMA-IR, HbA1c, TC, and CRP remained positively correlated with chemerin.

The regression analysis revealed that diabetic status and female sex were independently related to 25(OH)D status. In the adjusted chemerin model, chemerin was inversely and significantly associated with 25(OH)D (B −2.451, 95% CI −3.916: −0.986, p = 0.001). Diabetes and female sex were the only variables independently associated with MetS status in the logistic regression analysis.

Source: Results

Abstract: Conclusion

Individuals with T2DM showed lower serum 25(OH)D and increased chemerin concentrations than non-diabetic comparison participants. Chemerin was higher in participants with MetS, whereas neither 25(OH)D nor chemerin was independently associated with MetS in the adjusted logistic model. These findings support an association, rather than a causal or diagnostic relationship, between 25(OH)D, chemerin, and cardiometabolic disturbance in this cohort. Further longitudinal and interventional studies are required.

Source: Conclusion
Authors’ abstract

Background

This study investigated the associations of serum 25-hydroxyvitamin D [25(OH)D], the principal circulating marker used to assess vitamin D status, and chemerin with metabolic syndrome (MetS) components in individuals with type 2 diabetes mellitus (T2DM) and in a non-diabetic comparison group. The MetS components assessed were central obesity/waist circumference, blood pressure, fasting plasma glucose, triglycerides, and HDL-C, because these are the diagnostic elements of the International Diabetes Federation (IDF) definition.

Methods

This cross-sectional analytical study was conducted at King Abdulaziz University, Rabigh, between August 2021 and December 2022. Participants were classified as having MetS according to IDF criteria, and vitamin D status was classified using serum 25(OH)D concentrations as deficient, insufficient, or sufficient. Serum 25(OH)D, chemerin, and CRP were measured by ELISA.

Results

A total of 176 participants were included in the study (88 with diabetes and 88 non-diabetic comparison participants), with equal sex distribution in both groups (44 females and 44 males per group). Compared with the non-diabetic comparison group, participants with T2DM had significantly higher chemerin (p < 0.001) and significantly lower 25(OH)D (p < 0.001). The MetS was more common in diabetic participants than in non-diabetic comparison participants: 70/88 (79.5%) vs. 43/88 (48.9%) (p < 0.001). Blood chemerin levels were also elevated in those with MetS compared with those without MetS (p = 0.032).

Within the diabetic group, 18/88 (20.5%) had 25(OH)D deficiency and 47/88 (53.4%) had insufficient levels, whereas among non-diabetic comparison participants, 7/88 (8%) had deficiency and 32/88 (36.4%) had insufficient levels (p < 0.001). Higher FPG, insulin, HOMA-IR, HbA1c, TC, and CRP were associated with lower 25(OH)D in diabetic subjects. The latter inverse relationships were also observed in the MetS subgroup. Chemerin was associated with HOMA-IR, FPG, TC, CRP, and HbA1c in diabetic subjects. In the MetS subgroup, FPG, insulin, HOMA-IR, HbA1c, TC, and CRP remained positively correlated with chemerin.

The regression analysis revealed that diabetic status and female sex were independently related to 25(OH)D status. In the adjusted chemerin model, chemerin was inversely and significantly associated with 25(OH)D (B −2.451, 95% CI −3.916: −0.986, p = 0.001). Diabetes and female sex were the only variables independently associated with MetS status in the logistic regression analysis.

Conclusion

Individuals with T2DM showed lower serum 25(OH)D and increased chemerin concentrations than non-diabetic comparison participants. Chemerin was higher in participants with MetS, whereas neither 25(OH)D nor chemerin was independently associated with MetS in the adjusted logistic model. These findings support an association, rather than a causal or diagnostic relationship, between 25(OH)D, chemerin, and cardiometabolic disturbance in this cohort. Further longitudinal and interventional studies are required.

Publication and source details

Original title: Association of 25-hydroxyvitamin D and chemerin with metabolic syndrome components in individuals with type 2 diabetes mellitus

Mukhtiar Baig; Zohair Jamil Gazzaz; Mohamad Nidal Khabaz; Shahad Abduljalil Abualhamael; Sami Hamdan Alzahrani; Wail A. Alamoudi

Frontiers in Medicine · 2026

* Correspondence: Mukhtiar Baig, drmukhtiarbaig@yahoo.comCopyright © 2026 Baig, Gazzaz, Khabaz, Abualhamael, Alzahrani and Alamoudi.2026Baig, Gazzaz, Khabaz, Abualhamael, Alzahrani and Alamoudihttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. King Abdulaziz University10.13039/501100004054 The author(s) declared that financial support was received for this work and/or its publication. This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under Grant No. G-1436-828-585. The authors, therefore, acknowledge with thanks DSR's technical and financial support.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-08T17:28:00+00:00

DOI: 10.3389/fmed.2026.1907839 · PMC13493303